The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...
Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...
Data Highlights ACT for ALS as a Catalyst for Continued Progress in ALSWASHINGTON, Dec. 4, 2025 /PRNewswire/ -- I AM ALS ...
In March 2024, Kayla Gonzalez started having an odd sensation behind her right kneecap. At first, she didn’t think much of it. Then, the feeling started to spread. Soon, she had weakness in her calf, ...
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official ...
Study Finds on MSN
New blood test shows promise for faster ALS diagnosis
No more waiting months, or even over a year, for an ALS diagnosis? In A Nutshell A 46-gene blood test identified ALS patients with nearly 90% accuracy, even when tested on completely independent ...
Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig's disease, is an incurable neurological disorder affecting motor neurons—nerve cells in the brain and spinal cord that control voluntary muscle ...
On a quiet farm in Erie County, Pennsylvania, 67-year-old Diane Zaczyk used to think nothing of hefting 50-pound sacks of chicken feed onto her shoulder. Strong, stubborn and devoted to caring for her ...
News-Medical.Net on MSN
New rapid blood test enables early and accurate diagnosis of ALS
ALS is a debilitating paralytic disease characterized by the death of upper and lower motor neurons. Fortunately, ALS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback